First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - CLINICAL DESIGNS LIMITED

ANALYSIS
Credit Risk Update: CLINICAL DESIGNS LIMITED, C/O TC BULLEY DAVEY LTD, 1-4 LONDON ROAD, SPALDING, LINCOLNSHIRE, PE11 2TA. The legal status is a Private Limited Company and the current status at the registry of companies is Liquidation. The last filed accounts are dated 31 December 2022. The company was incorporated on 11 November 1999.

The accounts next due date is 30 September 2024. There are no mortgages.

The above was based on public record information as at 18 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 03875141
Date Incorporated: 11 November 1999
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 03875141
Annual Return: 31 July 2015
Registered Office: C/O TC BULLEY DAVEY LTD, 1-4 LONDON ROAD, SPALDING, LINCOLNSHIRE, PE11 2TA
SIC Code and Operations: 72200
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CLINICAL DESIGNS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 28 September 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
14824841 CLINICAL DETAILS LTD Active
07480489 CLINICAL DEVELOPMENT & SUPPORT SERVICES LIMITED Dissolved
07510297 CLINICAL DEVELOPMENT LIMITED Active
13565895 CLINICAL DEVELOPMENT RESOURCES LIMITED Active
06423812 CLINICAL DEVELOPMENT SOLUTIONS LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd